Background: Intravenous (IV) low molecular weight iron dextran is a safe and effective treatment for iron deficiency anemia (1). However, oral (PO) iron supplementation remains a preferred mode of iron repletion due to low cost and ease of administration. Unfortunately, the efficacy of PO iron varies due to differences in drug absorption and patient adherence. […]